Patient-Reported Symptoms in Climacteric Syndrome: Insights from a Network Analysis

Overview

This study identifies pain and hot flush as central symptoms in climacteric syndrome, highlighting distinct symptom clusters across menopausal stages. The findings underscore the importance of stage-specific assessment and management strategies in clinical practice.

Background

Specify the gap in literature regarding symptom reporting in climacteric syndrome.

Data Highlights

No numerical data available in the source material.

Key Findings

• Pain and hot flush were identified as the most central symptoms in the climacteric symptom network.
• Distinct symptom clusters were observed across different menopausal stages.
• The study utilized text mining and network analysis techniques to analyze patient-reported symptoms.
• Findings emphasize the need for stage-specific assessment and management strategies in clinical practice.
• Previous studies have primarily relied on surveys, highlighting a gap in understanding symptoms in patients with climacteric syndrome.

Clinical Implications

Clinicians should prioritize the assessment of pain and hot flush symptoms in patients presenting with climacteric syndrome. Stage-specific management strategies are recommended to address the unique symptom profiles of premenopausal and postmenopausal women.

Conclusion

This study provides valuable insights into the symptomatology of climacteric syndrome, reinforcing the need for tailored clinical approaches based on menopausal status.

Related Resources & Content

1. The ASCO Post, 2021 -- Survivors of Early-Stage Breast Cancer Face Broad Range of Symptoms and Concerns
2. BMC Psychiatry (Springer) -- Analyzing Networks in Adolescents Diagnosed with Somatic Symptom Disorders
3. The Journal of Clinical Endocrinology & Metabolism -- Indicators of Possible Androgen Excess Throughout the Lifespan in a Digital Cohort Study from the United States
4. Prevalence and severity of symptoms across the menopause transition: cross-sectional findings from the Australian Women's Midlife Years (AMY) Study - Monash University
5. Linking Gastrointestinal Symptoms to the Use of Specialty Care in Survivors of Colon Cancer: A Cohort Analysis
6. Safety of Fezolinetant for Treatment of Moderate to Severe Vasomotor Symptoms Due to Menopause: Pooled Analysis of Three Randomized Phase 3 Studies
7. Prevalence and severity of symptoms across the menopause transition: cross-sectional findings from the Australian Women's Midlife Years (AMY) Study - Monash University
8. https://www.imsociety.org/wp-content/uploads/2026/03/IMS-Recommendations-Full-Document.pdf